Carolyn White #conspiracy activistpost.com
“We’ve collected samples from all over the world, and cataloged the genetic information encoded in their DNA,” Dr. Holmes, Phylos’s chief science officer and molecular and evolutionary biologist, in addition to being a co-founder of Phylos Bioscience, told the NY Times, relating the DNA sequencing to an actual bar code in terms of identification and evolutionary relationship relative to other samples.
The data could theoretically help protect the intellectual property rights of growers from potential big business interests, such as Monsanto, from gaining a patent foothold in the growing industry.
Due to the social media attention given to the subject, Monsanto has attempted to refute any interest in producing GMO cannabis, posting on their website that the companies reported interest in GMO marijuana is nothing more than “an Internet rumor.”
Additionally, on April 25, Monsanto spokeswoman Charla Lord told Willamette Week that the company will not be getting involved in the marijuana business.
“Monsanto has not, is not and has no plans for working on cultivating cannabis,” Lord told WW.
Contrary to the public statements by Lord, White says that he expects companies like Monsanto will attempt to eventually patent cannabis.